Frontiers in Science & Technology| Upcoming Events

• Main
• Steering Committee
• Past Presenters
• In the News
• Upcoming Events
• Events Calendar

In Search of Less Toxic Cancer Therapies

Presented by:

Catriona Jamieson, M.D., Ph.D.
Professor, Pathology
Assistant Professor, Medicine, Hematologic Malignancies
Program, UC San Diego; Director, Stem Cell Research
Program, Moores UC San Diego Cancer Center

In partnership with:

Program overview:
In the past two years, Dr. Jamieson has identified a promising cancer treatment in the laboratory and is completing the first clinical trial to target cancer stems cells in humans. Her goal is to find more selective, less toxic therapies.

Her current research specializes in myeloproliferative disorders (MPDs) and leukemia. Myeloproliferative neoplasms are a family of unusual degenerative disorders in which the body overproduces blood cells. Myeloproliferative neoplasms can cause blood clots triggering reactions such as heart attack, stroke, deep vein thrombosis, and pulmonary embolism, as well as develop into acute myelogenous leukemia. Although some effective treatments are available, they are laden with serious side effects. In addition, individuals tend to become resistant to the treatments.

Through her studies of mutant stem cells and progenitor cells in myeloproliferative neoplasms, Dr. Jamieson has found that these cells can give rise to cancer stem cells. Cancer stem cells are inclined to lie low to evade chemotherapy and then activate again later, causing disease progression and resistance to treatment.

Who should attend:
Scientists, engineers, physicians, healthcare leaders, venture capitalists, technology and life sciences professionals, services providers, and business leaders.

About the presenter:
Catriona Jamieson, M.D., Ph.D., is the Director of the Stem Cell Research Program at the Moores UC San Diego Cancer Center, a hematologist-oncologist and stem cell biologist. She became an Instructor in Hematology at Stanford in 2003, following a post-doctoral stem cell biology research fellowship in the laboratory of Dr. Irving L. Weissman, and joined the UC San Diego faculty of medicine in November 2005. At UC San Diego, she has continued to build on her national and international reputation for her translational research on stem cells and cancer particularly in the area of hematologic malignancies. She was the first recipient of a CIRM grant to derive and characterize cancer stem cells from embryonic stem cells, has received a number of awards and honors, including the Forbeck Scholar Award, has numerous patents and publications, served as Vice-Chair (2009) and will be the Chair of the Stem Cells and Cancer Gordon Conference (2011). She received her B.Sc. in Biology (Genetics) from the University of British Columbia as well as her Ph.D. in Microbiology and M.D. After completing a residency program in Internal Medicine, she trained at Stanford University Medical Center in bone marrow transplantation and hematology.

Date: January 26, 2010
Time: 12:00 noon – 1:30 p.m.
Location: AMN Healthcare
12400 High Bluff Drive # 100
San Diego, CA 92130
Note: Lunch will be provided for participants.
Contact: Bethany Kraynack
Email: bkraynack@connect.org
Phone: 858-964-1312
Fees: CONNECT Members: $15
Non-Members: $25
Students: $10
At the Door $35
Register Here

Agenda:
12:00 pm - Registration, Lunch & Networking
12:20 pm - CONNECT Welcome, Sponsor Introduction
12:25 pm - Sponsor Welcome, Speaker Introduction
12:30 pm - Speaker Presentation
1:15 pm - Q & A
1:30 pm - Evaluations & Close

To suggest future speakers or topics please contact Bethany Kraynack at bkraynack@connect.org or 858.964.1312

Program Contact: